JMS Co.,Ltd. (TSE:7702) agreed to acquire blood purification business from Japan Lifeline Co., Ltd. (TSE:7575) on February 26, 2021. For year ended march 2020, Blood purification business reported revenues of ¥914 million. Japan Lifeline Co., Ltd.'s borad approved the transaction on February 26, 2021.

The transaction is expected to close on April 1, 2021. Japan Lifeline expects that this business divestment has no material impact on the consolidated results for the year ending March 31, 2021.